[HTML][HTML] The versatile role of exosomes in human retroviral infections: from immunopathogenesis to clinical application

J Rezaie, C Aslan, M Ahmadi, NM Zolbanin… - Cell & Bioscience, 2021 - Springer
Eukaryotic cells produce extracellular vesicles (EVs) mediating intercellular communication.
These vesicles encompass many bio-molecules such as proteins, nucleic acids, and lipids …

[HTML][HTML] Co-Infection and Cancer: Host–Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses

TH Mulherkar, DJ Gómez, G Sandel, P Jain - Viruses, 2022 - mdpi.com
Dendritic cells (DCs) function as a link between innate and adaptive immune responses.
Retroviruses HIV-1 and HTLV-1 modulate DCs to their advantage and utilize them to …

Regulation of HTLV-1 transformation

KJ Ernzen, AR Panfil - Bioscience reports, 2022 - portlandpress.com
Human T-cell leukemia virus type 1 (HTLV-1) is the only identified oncogenic human
retrovirus. HTLV-1 infects approximately 5–10 million people worldwide and is the infectious …

Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review

A Letafati, R Soheili, M Norouzi, P Soleimani… - Medical Oncology, 2023 - Springer
Adult T-cell leukemia/lymphoma (ATLL), an infrequent malignancy resultant from human T-
cell lymphotropic virus type I (HTLV-1), exhibits a spectrum of phenotypes, encompassing …

[HTML][HTML] How can we prevent mother-to-child transmission of HTLV-1?

K Itabashi, T Miyazawa, K Uchimaru - International Journal of Molecular …, 2023 - mdpi.com
The perception of human T-cell leukemia virus type 1 (HTlV-1) infection as a “silent disease”
has recently given way to concern that its presence may be having a variety of effects. HTLV …

[HTML][HTML] Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years

CS Santana, FO Andrade, GCS da Silva… - Frontiers in …, 2023 - frontiersin.org
Introduction The Human T-lymphotropic virus type 1 (HTLV-1) was the first described human
retrovirus. It is currently estimated that around 5 to 10 million people worldwide are infected …

[HTML][HTML] An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus …

AT Moin, NA Rani, MA Ullah, RB Patil, TB Robin… - Plos one, 2023 - journals.plos.org
Human T-lymphotropic virus (HTLV), a group of retroviruses belonging to the oncovirus
family, has long been associated with various inflammatory and immunosuppressive …

HTLV, a multi organ oncovirus

S Ramezani, SA Rezaee, Z Farjami, N Ebrahimi… - Microbial …, 2022 - Elsevier
Human T lymphotropic virus (HTLV-I) is a retrovirus that has been recognized as a causative
agent of two crucidal diseases, HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis …

Dry eye disease caused by viral infection: Past, present and future

M Wu, C Sun, Q Shi, Y Luo, Z Wang, J Wang, Y Qin… - Virulence, 2024 - Taylor & Francis
Following viral infection, the innate immune system senses viral products, such as viral
nucleic acids, to activate innate defence pathways, leading to inflammation and apoptosis …

[HTML][HTML] Role of miRNAs in human T cell leukemia virus type 1 induced T cell leukemia: a literature review and bioinformatics approach

CB Machado, LS da Cunha, JHS Maués… - International Journal of …, 2022 - mdpi.com
Human T cell leukemia virus type 1 (HTLV-1) was identified as the first pathogenic human
retrovirus and is estimated to infect 5 to 10 million individuals worldwide. Unlike other …